Airdate: Tuesday, November 8, 2022 Season: 1 Episode: 10
Guest: Chris Rand
On this episode of #IndustryInsights, we spoke with Chris Rand, MSc, Sales and Marketing Manager at Aurora Scientific. Chris delves into the start and evolution of Aurora Scientific, and their journey within the preclinical research world. He also discusses their advance into the neuroscience space, plus some insight into how the company may expand in the near future. Listen to find out what exciting new Industry Insights are coming from Aurora Scientific!
Read the full blog and watch the interview here.
Similar Podcasts
#ExpertAnswers: Sarah Greising on Muscle Injury Recovery
Sarah Greising discusses the current pathophysiologic understanding of the skeletal muscle remaining following traumatic musculoskeletal injuries.
#ExpertAnswers: Bradley Palmer on Measuring Cardiac Tissue
Bradley Palmer answers questions from a recent webinar where he highlighted and demonstrated the challenging preparation of cardiac tissue slices and measurement of force and calcium.
Talking Real Science with Chris Perry
Chris Perry shares his career path and recent project of creating a CRO to bring more opportunity to deliver solutions for muscle disorders while still benefiting his trainees.
Related Content
Control of Muscle Glucose Uptake in vivo: Thinking Outside the Myocyte
In this webinar, David Wasserman, PhD provides a more complete understanding of muscle glucose uptake through consideration of the integration of physiological systems that control this process.
Cut and Paste of Myosin Binding Protein-C in Striated Muscles
Dr. Samantha Harris discusses the development of three new mouse models in her lab, engineered to target and replace specific myosin binding protein-C paralogs in muscle fibers and impact of their mutations on skeletal and cardiac muscle diseases.
Integrating Patient Engagement and Trainee Development in Pre-Clinical Research
Christopher Perry, PhD discusses how his laboratory aims to discover mechanisms by which metabolic dysfunction causes muscle weakness and apply these findings to develop new therapies for muscle disorders. Homira Osman, PhD provides a particular focus on leveraging scientific findings for practice and policy and linking trainees with patient communities.